Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 25;3(1):e167.
doi: 10.1002/deo2.167. eCollection 2023 Apr.

Assessment of photodynamic therapy as a salvage treatment for local failure after chemoradiotherapy or radiotherapy for esophageal cancer in patients aged 80 years or older

Affiliations

Assessment of photodynamic therapy as a salvage treatment for local failure after chemoradiotherapy or radiotherapy for esophageal cancer in patients aged 80 years or older

Michiko Nishikawa et al. DEN Open. .

Abstract

Objectives: Chemoradiotherapy (CRT) or radiotherapy (RT) alone is often the treatment of choice for elderly patients with esophageal cancer with the expectation of organ preservation. However, salvage treatment remains a problem when endoscopic resection is not indicated for local failure after CRT/RT. Photodynamic therapy (PDT) is indicated for local failure after CRT/RT, but there are few reports on its efficacy and safety in elderly patients. This study aimed to assess the outcome of PDT for local failure after CRT/RT for esophageal cancer in elderly patients.

Methods: This retrospective single-center study included 42 patients who first underwent PDT between April 2013 and June 2021. Patients aged ≥80 and <80 years were classified into the elderly and nonelderly groups, respectively. Local complete response rate, overall survival, progression-free survival, and incidence of adverse events related to PDT were compared retrospectively between the groups.

Results: The local complete response rate was 93.3% in the elderly group and 85.7 in the non-elderly group. The 2-year overall survival rate was 68.6% and 72.5%, and the 2-year progression-free survival rate was 49.5% and 70.0% in the elderly and nonelderly groups, respectively. There was no significant difference in any of these outcomes between the groups. In terms of adverse events, pneumonia and delirium tended to occur more frequently in the elderly group, but there were no serious adverse events in either group.

Conclusion: The outcome of salvage PDT in the local control was comparable between the elderly and nonelderly patients for local failure after CRT/RT for esophageal cancer.

Keywords: aged; chemoradiotherapy; esophageal neoplasms; photochemotherapy; salvage therapy.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

FIGURE 1
FIGURE 1
Flowchart of patient selection
FIGURE 2
FIGURE 2
Overall survival and progression‐free survival. (a) Kaplan–Meier OS and (b) PFS curves after PDT. There was no significant difference in OS or PFS between the elderly and nonelderly groups. OS, overall survival; PFS, progression‐free survival; PDT, photodynamic therapy
FIGURE 3
FIGURE 3
Clinical course in the elderly and nonelderly groups after PDT. (a) Elderly group. Recurrence of esophageal cancer at a different site to PDT PDT, photodynamic therapy; L‐CR, local complete response; L‐nonCR, local non‐complete response. (b) Non‐elderly group. §Distant metastasis of esophageal cancer PDT, photodynamic therapy; L‐CR, local complete response; L‐nonCR, local non‐complete response
FIGURE 4
FIGURE 4
Endoscopic examination of a patient aged 80 years who achieved L‐CR after PDT. (a) Before PDT. A local recurrence lesion after chemoradiotherapy in the middle thoracic esophagus. The tumor depth was diagnosed as T2. (b) One year after PDT. There was no evidence of recurrence. PDT, photodynamic therapy; L‐CR, local complete response

Similar articles

Cited by

References

    1. World Health Organization . Oesophagus cancer fact sheet [Internet]. World Health Organization, International Agency for Research on Cancer, GLOBOCAN; 2020 [Cited 2022 May 20]. Available from: https://gco.iarc.fr/today/data/factsheets/cancers/6‐Oesophagus‐fact‐shee....
    1. Kitagawa Y, Uno T, Oyama T et al. Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society. Esophagus 2019; 16: 1–43. - PMC - PubMed
    1. Mantziari S, Teixeira Farinha H, Bouygues V et al. Esophageal cancer in elderly patients, current treatment options and outcomes: A systematic review and pooled analysis. Cancers Published online: 27 April 2021; DOI: 10.3390/cancers13092104 - DOI - PMC - PubMed
    1. Herskovic A, Martz K, al‐Sarraf M et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992; 326: 1593–8. - PubMed
    1. Hironaka S, Ohtsu A, Boku N et al. Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2–3)N(any)M(0) squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 2003; 57: 425–33. - PubMed